Platelet responses to pharmacological and physiological interventions in middle‐aged men with different habitual physical activity levels
- 19 January 2018
- journal article
- research article
- Published by Wiley in Acta Physiologica
- Vol. 223 (1) , e13028
Abstract
The current guidelines following an acute coronary syndrome recommend dual‐antiplatelet therapy (DAPT) (aspirin plus a P2Y12 antagonist) alongside lifestyle modifications, including more regular physical activity. It is currently unknown whether regular exercise affects the pharmacology of DAPT.Aim: To explore how exercise‐induced improvements in vascular and platelet function affect the efficacy of DAPT, in a cross‐sectional study of men with different physical activity levels (training status).Methods: A total of 42 healthy, normal‐weight, middle‐aged men were divided into 3 groups: untrained, moderately trained and well‐trained. Their platelet reactivity (agonist‐induced % aggregation) was investigated in platelet‐rich plasma at rest and after inhibition with aspirin and ticagrelor and/or prostacyclin and nitric oxide added to the blood in vitro, and after physiological tests of vascular function; passive movement of the leg, flow‐mediated dilation and one‐leg knee‐extensor exercise. Vascular function of the femoral artery (changes in arterial blood flow) was assessed by ultrasound Doppler.Results: Platelets from the well‐trained subjects had lower basal reactivity, a higher sensitivity to the anti‐aggregatory effects of prostacyclin and were more potently inhibited by DAPT compared to the untrained subjects. The moderately trained and well‐trained subjects had a superior vascular function compared to untrained subjects, and their platelets were more inhibited by the passive movement, flow‐mediated dilation and one‐leg knee‐extensor exercise.Discussion: A habitually active lifestyle leads to an increased platelet sensitivity to pharmacological and physiological platelet inhibitors. We suggest that physical activity habits (training status) should be considered when personalizing and optimizing antithrombotic treatment strategies.Keywords
Funding Information
- Det Frie Forskningsråd (DFF‐6110‐0032, DFF‐4092‐00376)
- British Heart Foundation (PG/15/79/31777, PG/15/47/31591)
This publication has 27 references indexed in Scilit:
- Blockade of the purinergic P2Y 12 receptor greatly increases the platelet inhibitory actions of nitric oxideProceedings of the National Academy of Sciences, 2013
- Optical multichannel (optimul) platelet aggregometry in 96-well plates as an additional method of platelet reactivity testingPlatelets, 2011
- Standardised optical multichannel (optimul) platelet aggregometry using high-speed shaking and fixed time point readingsPlatelets, 2011
- The relationship of mean platelet volume with the risk and prognosis of cardiovascular diseasesInternational Journal Of Clinical Practice, 2009
- From ATP to AZD6140: The discovery of an orally active reversible P2Y12 receptor antagonist for the prevention of thrombosisBioorganic & Medicinal Chemistry Letters, 2007
- The effect of exercise and training status on platelet activation: Do cocoa polyphenols play a role?Platelets, 2006
- The re‐establishment of the normal blood lactate response to exercise in humans after prolonged acclimatization to altitudeThe Journal of Physiology, 2001
- Effect of Strenuous, Acute Exercise on α2-Adrenergic Agonist–Potentiated Platelet ActivationArteriosclerosis, Thrombosis, and Vascular Biology, 1999
- Different effects of strenuous exercise and moderate exercise on platelet function in men.Circulation, 1994
- Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosisThe Lancet, 1992